Actively Recruiting

Phase 1
Age: 21Years - 35Years
All Genders
Healthy Volunteers
NCT03827460

Sex Differences in the Response to Abstinence From Alcohol.

Led by Indiana University · Updated on 2025-12-18

160

Participants Needed

1

Research Sites

385 weeks

Total Duration

On this page

Sponsors

I

Indiana University

Lead Sponsor

N

National Institute on Alcohol Abuse and Alcoholism (NIAAA)

Collaborating Sponsor

AI-Summary

What this Trial Is About

In laboratory animals, repeated cycles of abstinence from and return to alcohol drinking can lead to changes in alcohol intake. In a study of the effect of abstinence on drinking in humans, the investigators found evidence that abstinence affects drinking differently in women compared to men. In the present study, the investigators propose to study how men and women respond to abstinence, and whether this information can be used to improve intervention and prevention strategies.

CONDITIONS

Official Title

Sex Differences in the Response to Abstinence From Alcohol.

Who Can Participate

Age: 21Years - 35Years
All Genders
Healthy Volunteers

Eligibility Criteria

Eligible

You may qualify if you...

  • Moderate social drinkers
  • Able to understand/complete questionnaires and procedures in English
  • Body mass index (BMI) between 18.5 and 32 kg/m2
  • Have venous access sufficient to allow blood sampling
Not Eligible

You will not qualify if you...

  • Pregnant or breast-feeding women, or women who intend to become pregnant
  • Do not attest to using accepted forms of birth control for the infusion phase of the study
  • Current treatment for, or desire to be treated for, any substance use disorder or court ordered to not drink alcohol
  • History of significant adverse reaction to alcohol
  • Medical disorders or other conditions such as alcohol withdrawal seizures or delirium tremens that may influence study outcome or participant safety
  • Medications (past 30 days) that could influence data or participant safety (e.g. antidepressants, antipsychotics, benzodiazepines, etc.) as determined by investigators
  • DSM 5 Disorders (non AUD) or current/history of neurological disease of cerebral origin, or head injury with > 20 min loss of consciousness
  • Positive breath alcohol reading on arrival at any study visit
  • Actively suicidal (for example, any suicide attempts within the past year or any current suicidal intent, including a plan) or are at serious suicidal risk, by clinical judgment of the investigator
  • Any condition for which the principal investigators determine it is unsafe or not prudent to enroll

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

University Hospital

Indianapolis, Indiana, United States, 46202

Actively Recruiting

Loading map...

Research Team

A

Ann E Kosobud, Ph.D.

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

BASIC_SCIENCE

Number of Arms

3

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here